Golden Meditech and MD Anderson Team Up to Create Cellenkos, Inc.

September 18th 2016


HONG KONG and HOUSTON, Sept. 18, 2016 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a Hong Kong-based integrated healthcare enterprise, and The University of Texas at MD Anderson Cancer Center ("MD Anderson") have announced the creation of Cellenkos, Inc. ("Cellenkos"), a start-up enterprise focused on umbilical cord blood derived T-regulatory ("T-reg") cellular therapies.

http://www.prnewswire.com/news-releases/golden-meditech-and-md-anderson-team-up-to-create-cellenkos-inc-300329880.html